Browsing Centre for Immunobiology by Author "Baeten, JM"
Now showing items 1-1 of 1
-
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
Sax, PE; Arribas, JR; Orkin, C; Lazzarin, A; Pozniak, A; DeJesus, E; Maggiolo, F; Stellbrink, H-J; Yazdanpanah, Y; Acosta, R (2023-05)BACKGROUND: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a single-tablet regimen recommended for HIV-1 treatment. The safety and efficacy of B/F/TAF as initial therapy was established in two Phase 3 studies: ...